COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOF
Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; slv |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PAIK Sang Hoon PARK Yoo Chang KIM Yong-Chul SEO Jinwook CHOI Yong Woon JIN Thong-Gyu SON Jong Mun CHUNG Yo Kyung |
description | Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI2723369TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI2723369TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI2723369TT23</originalsourceid><addsrcrecordid>eNqNjE0KwjAQRrtxIeod4gG6SUFxObYTE2hmSjJZlyJx5U-h3h-1egBXH4_v8ZbFrWbfcXTimBRQowwHn1qY-fMFFx2dVMA3HB0BibLJAynXpMAEgqUuY2oNCEScE13ADsI34VEsN0osBmSzLhaX4TrlzW9Xxdag1LbM46PP0zic8z0_--j0XlfV7iCiq3-cF45zN_4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOF</title><source>esp@cenet</source><creator>PAIK Sang Hoon ; PARK Yoo Chang ; KIM Yong-Chul ; SEO Jinwook ; CHOI Yong Woon ; JIN Thong-Gyu ; SON Jong Mun ; CHUNG Yo Kyung</creator><creatorcontrib>PAIK Sang Hoon ; PARK Yoo Chang ; KIM Yong-Chul ; SEO Jinwook ; CHOI Yong Woon ; JIN Thong-Gyu ; SON Jong Mun ; CHUNG Yo Kyung</creatorcontrib><description>Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.</description><language>eng ; slv</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230831&DB=EPODOC&CC=SI&NR=2723369T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230831&DB=EPODOC&CC=SI&NR=2723369T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAIK Sang Hoon</creatorcontrib><creatorcontrib>PARK Yoo Chang</creatorcontrib><creatorcontrib>KIM Yong-Chul</creatorcontrib><creatorcontrib>SEO Jinwook</creatorcontrib><creatorcontrib>CHOI Yong Woon</creatorcontrib><creatorcontrib>JIN Thong-Gyu</creatorcontrib><creatorcontrib>SON Jong Mun</creatorcontrib><creatorcontrib>CHUNG Yo Kyung</creatorcontrib><title>COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOF</title><description>Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE0KwjAQRrtxIeod4gG6SUFxObYTE2hmSjJZlyJx5U-h3h-1egBXH4_v8ZbFrWbfcXTimBRQowwHn1qY-fMFFx2dVMA3HB0BibLJAynXpMAEgqUuY2oNCEScE13ADsI34VEsN0osBmSzLhaX4TrlzW9Xxdag1LbM46PP0zic8z0_--j0XlfV7iCiq3-cF45zN_4</recordid><startdate>20230831</startdate><enddate>20230831</enddate><creator>PAIK Sang Hoon</creator><creator>PARK Yoo Chang</creator><creator>KIM Yong-Chul</creator><creator>SEO Jinwook</creator><creator>CHOI Yong Woon</creator><creator>JIN Thong-Gyu</creator><creator>SON Jong Mun</creator><creator>CHUNG Yo Kyung</creator><scope>EVB</scope></search><sort><creationdate>20230831</creationdate><title>COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOF</title><author>PAIK Sang Hoon ; PARK Yoo Chang ; KIM Yong-Chul ; SEO Jinwook ; CHOI Yong Woon ; JIN Thong-Gyu ; SON Jong Mun ; CHUNG Yo Kyung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI2723369TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>PAIK Sang Hoon</creatorcontrib><creatorcontrib>PARK Yoo Chang</creatorcontrib><creatorcontrib>KIM Yong-Chul</creatorcontrib><creatorcontrib>SEO Jinwook</creatorcontrib><creatorcontrib>CHOI Yong Woon</creatorcontrib><creatorcontrib>JIN Thong-Gyu</creatorcontrib><creatorcontrib>SON Jong Mun</creatorcontrib><creatorcontrib>CHUNG Yo Kyung</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAIK Sang Hoon</au><au>PARK Yoo Chang</au><au>KIM Yong-Chul</au><au>SEO Jinwook</au><au>CHOI Yong Woon</au><au>JIN Thong-Gyu</au><au>SON Jong Mun</au><au>CHUNG Yo Kyung</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOF</title><date>2023-08-31</date><risdate>2023</risdate><abstract>Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; slv |
recordid | cdi_epo_espacenet_SI2723369TT2 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOF |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A02%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAIK%20Sang%20Hoon&rft.date=2023-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI2723369TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |